CELULARITY INC.

Analyst Reco. Celularity Inc.

Equities

CELU

US1511902041

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
3.05 ^USD	-7.85%		0.00%	+23.28%

Mar. 26	Celularity Receives Healthcare Common Procedure Coding System Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance 3L	CI
Mar. 20	Celularity Seeks FDA Orphan Drug Status for PDA-002 in Facioscapulohumeral Muscular Dystrophy	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Lowers Price Target on Celularity to $2.50 From $15, Maintains Buy Rating	23-01-30	MT
Morgan Stanley Downgrades Celularity to Underweight From Equalweight, Adjusts Price Target to $1 From $5	23-01-30	MT
Oppenheimer Downgrades Celularity to Perform From Outperform, Removes $6 Price Target	22-12-22	MT
Oppenheimer Adjusts Celularity Price Target to $6 From $8, Maintains Outperform Rating	22-11-14	MT
Morgan Stanley Trims Celularity's Price Target to $5 From $8, Keeps Equalweight Rating	22-09-12	MT
Alliance Global Partners Initiates Coverage on Celularity With Buy Rating, $15 Price Target	22-08-25	MT
Truist Securities Trims Price Target on Celularity to $6 From $10, Reiterates Hold Rating	22-08-23	MT
Oppenheimer Adjusts Celularity Price Target to $8 From $10, Maintains Outperform Rating	22-08-11	MT
HC Wainwright Starts Celularity at Buy With $15 Price Target	22-06-22	MT
Truist Securities Downgrades Celularity to Hold From Buy	22-04-06	MT
Oppenheimer Initiates Celularity With Outperform Rating, $9 Price Target	22-01-28	MT
Celularity Stock Drops as Morgan Stanley Initiates Ratings Coverage at Equal-Weight	21-11-24	MT
Morgan Stanley Starts Celularity at Equal-Weight With $9 Price Target	21-11-24	MT
CELULARITY : Truist Securities Initiates Celularity Class at Buy Rating With $12 Price Target	21-10-19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW